List of Excipients in API methocarbamol tablets
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing methocarbamol tablets
Detailed excipient profiles for methocarbamol tablets
Excipient focus: CI 15985
methocarbamol tablets drug variants containing CI 15985
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | methocarbamol tablets | 50090-3756 |
| >Company | >Ingredient | >NDC |
methocarbamol tablets drug variants not containing CI 15985
Excipient focus: CROSPOVIDONE
methocarbamol tablets drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Proficient Rx LP | methocarbamol tablets | 71205-068 |
| >Company | >Ingredient | >NDC |
methocarbamol tablets drug variants not containing CROSPOVIDONE
Excipient focus: FD&C YELLOW NO. 6
methocarbamol tablets drug variants containing FD&C YELLOW NO. 6
methocarbamol tablets drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | methocarbamol tablets | 50090-3756 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
methocarbamol tablets drug variants containing HYDROXYPROPYL CELLULOSE
methocarbamol tablets drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
methocarbamol tablets drug variants containing HYPROMELLOSE 2910
methocarbamol tablets drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
methocarbamol tablets drug variants containing POLYSORBATE 80
methocarbamol tablets drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
methocarbamol tablets drug variants containing POVIDONE
methocarbamol tablets drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Proficient Rx LP | methocarbamol tablets | 71205-068 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
methocarbamol tablets drug variants containing PROPYLENE GLYCOL
methocarbamol tablets drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
methocarbamol tablets drug variants containing SILICON DIOXIDE
methocarbamol tablets drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
methocarbamol tablets drug variants containing SODIUM LAURYL SULFATE
methocarbamol tablets drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
methocarbamol tablets drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
methocarbamol tablets drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
methocarbamol tablets drug variants containing STARCH, CORN
methocarbamol tablets drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
methocarbamol tablets drug variants containing STEARIC ACID
methocarbamol tablets drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
methocarbamol tablets drug variants containing TITANIUM DIOXIDE
methocarbamol tablets drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch